Article Details

Viatris wins FDA approval for first generic of AstraZeneca's Symbicort - Seeking Alpha

Retrieved on: 2022-03-16 03:48:29

Tags for this article:

Click the tags to see associated articles and topics

Viatris wins FDA approval for first generic of AstraZeneca's Symbicort - Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/3813823-viatris-wins-fda-approval-for-generic-of-astrazenecas-symbicort

Excerpt

Symbicort generated $2.7 billion revenue for AstraZeneca (AZN) in 2021 with a ~2% YoY decline in constant currency terms.

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up